Covidien (COV +2.2%) agrees to sell its Specialty Chemicals business to an affiliate of New...

|By:, SA News Editor

Covidien (COV +2.2%) agrees to sell its Specialty Chemicals business to an affiliate of New Mountain Capital for $280M. The deal is expected to dilute EPS by $0.09-$0.11 in FY10 and FY11. (PR)